1-9 of 9
re-ly trial
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Measuring the Anticoagulation Effects of Exosite I Thrombin Inhibitors: Utility and Limitations of Clotting Assays, Thromboelastography, and Calibrated Automated Thrombography

Matthew Bunce, PhD, Zheng Huang Devine, PhD, Madhu Chintala, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1115.
https://doi.org/10.1182/blood.V130.Suppl_1.1115.1115
Published: 2017
Journal Articles

Comparison of Stroke- and Bleed-Specific Healthcare Resource Utilization and Costs Among Patients with Non-Valvular Atrial Fibrillation, Newly Treated with Dabigatran or Warfarin

Xue Song, PhD, Pranav Gandhi, BPharm, MS, PhD, Adrienne M Gilligan, PhD, Prachi Arora, BPharm, MS, Caroline Henriques, MPH, Cheng Wang, MD PhD, Stephen Sander, PharmD, David M Smith, PhD
Journal: Blood
Blood (2016) 128 (22): 532.
https://doi.org/10.1182/blood.V128.22.532.532
Published: 2016
Journal Articles

Do the Safety and Efficacy Outcomes Reported in the Clinical Trials of Direct Oral Anticoagulants (DOAC) Translate to the Real-World?

Shammim Haji, MPharm, Jignesh P Patel, PhD, Vivian Auyeung, PhD, Lara N Roberts, MD, Julia Czuprynska, MBBS, Raj K Patel, MD, Roopen Arya, PhD
Journal: Blood
Blood (2015) 126 (23): 2335.
https://doi.org/10.1182/blood.V126.23.2335.2335
Published: 2015
Journal Articles

Comparison of Medical Costs Avoided When New Oral Anticoagulants Are Used for the Treatment of Patients with Atrial Fibrillation and Venous Thromboembolism in the U.S

Alpesh N Amin, MDMBA, Amanda Bruno, PhD MPH, Jeffrey Trocio, MPH, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD
Journal: Blood
Blood (2014) 124 (21): 2181.
https://doi.org/10.1182/blood.V124.21.2181.2181
Published: 2014
Journal Articles

Dabigatran Etexilate and Risk Of Myocardial Infarction, Major Bleeding and All-Cause Mortality: A Systematic Review and Meta-Analysis Of Randomized Controlled Trials

Jonathan Douxfils, Pharm D, PhD Student, Fanny Buckinx, François Mullier, PhD, Valentine Minet, Pharm D, PhD Student, Véronique Rabenda, Jean-Yves Reginster, Professor, Christian Chatelain, Professor, Philippe Hainaut, Professor, Olivier Bruyère, Professor, Jean-Michel Dogné, Professor
Journal: Blood
Blood (2013) 122 (21): 3633.
https://doi.org/10.1182/blood.V122.21.3633.3633
Published: 2013
Journal Articles

Comparison of Cost-Effectiveness of Anticoagulation with Dabigatran, Rivaroxaban and Apixaban in Patients with Non-Valvular Atrial Fibrillation Across Countries

Martin Krejczy, Job Harenberg, Prof., Dr., Svetlana Marx, Konrad Obermann, Prof., Dr., Martin Wehling, Prof., Dr.
Journal: Blood
Blood (2012) 120 (21): 1164.
https://doi.org/10.1182/blood.V120.21.1164.1164
Published: 2012
Journal Articles

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Vera Gelbricht, Sebastian Werth, MD, Christina Koehler, Ulrike Haensel, Luise Tittl, Ines Beyer-Westendorf, Thomas Schreier, Jan Beyer-Westendorf, MD
Journal: Blood
Blood (2012) 120 (21): 502.
https://doi.org/10.1182/blood.V120.21.502.502
Published: 2012
Journal Articles

Indirect Comparisons of the New Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation

Shabnam Zolfaghari, Jr., M.Sc., Job Harenberg, Prof., Dr., Svetlana Marx, Martin Wehling, Prof., Dr.
Journal: Blood
Blood (2012) 120 (21): 4363.
https://doi.org/10.1182/blood.V120.21.4363.4363
Published: 2012
Journal Articles

Management and Outcomes of Major Bleeding On Dabigatran or Warfarin

Ammar Majeed, Hun-Gyu Hwang, Martina Brueckmann, MD, Stuart Connolly, MD, John Eikelboom, Michael Ezekowitz, MB, ChB, DPhil, Lars Wallentin, MD, PhD, Salim Yusuf, FRCPC, DPhil, Sam Schulman, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 19.
https://doi.org/10.1182/blood.V120.21.19.19
Published: 2012